Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    "Chiari malformation type 2"
Show Display Options
RSS Create an RSS feed from your search for:
"Chiari malformation type 2"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Genetic Analysis of the Chiari I Malformation
Conditions: Syringomyelia;   Type I Arnold Chiari Malformation
Intervention:
2 Recruiting Efficacy of Acetaminophen in Posterior Fossa Surgery
Conditions: Arnold-Chiari Malformation;   Posterior Fossa Tumors
Interventions: Drug: IV acetaminophen;   Drug: normal saline
3 Recruiting Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2
Conditions: Keratoconus;   Corneal Ectasia
Interventions: Drug: Riboflavin 0.1% ophthalmic solution;   Device: CCL-VARIO UV lamp;   Device: CCL-VARIO at 18 mW/cm2
4 Unknown  Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
Condition: Venous Leg Ulcers
Interventions: Biological: HP802-247;   Biological: Vehicle
5 Completed Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
6 Completed Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2
Condition: Actinic Keratosis
Intervention: Drug: PEP005 Topical gel
7 Completed Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204;   Drug: Placebo
8 Completed Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: ingenol mebutate;   Other: Placebo
9 Recruiting NOVOCART®3D for Treatment of Articular Cartilage of the Knee
Condition: Articular Cartilage of the Femoral Condyle Between 2-6cm2
Interventions: Procedure: microfracture;   Biological: NOVOCART 3D
10 Not yet recruiting Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
Conditions: Arnold-Chiari Malformation, Type 1;   Chiari Malformation Type I;   Type I Arnold-Chiari Malformation;   Syringomyelia
Interventions: Procedure: Posterior fossa decompression;   Procedure: Dural Augmentation
11 Active, not recruiting Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest
Condition: Actinic Keratosis
Intervention: Drug: Ingenol Mebutate
12 Terminated Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Condition: Keratoconus
Intervention: Drug: Riboflavin drops
13 Completed
Has Results
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Condition: Keratosis
Intervention: Drug: imiquimod cream
14 Completed
Has Results
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Condition: Healthy Volunteers
Intervention: Drug: Rotigotine transdermal patch
15 Completed
Has Results
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
16 Completed A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204 Formulation 1;   Drug: LEO 43204 Formulation 2;   Drug: LEO 43204 Formulation 1 Dose X;   Drug: LEO 43204 Formulation 1 Dose Y;   Drug: LEO 43204 Formulation 2 Dose XX;   Drug: LEO 43204 Formulation 2 Dose YY;   Drug: Placebo Formulation 1;   Drug: Placebo Formulation 2
17 Completed Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Condition: Healthy
Intervention: Drug: Rotigotine transdermal patch
18 Completed Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch
Condition: Healthy
Intervention: Drug: testosterone
19 Completed Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel;   Drug: placebo
20 Completed
Has Results
Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
Condition: Hypogonadism
Intervention: Drug: testosterone matrix transdermal system

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.